Biological Mimetics

Biological Mimetics

Biotechnology, 124 Byte Dr, Frederick, Maryland, 21702, United States, 11-50 Employees

biologicalmimetics.com

  • LinkedIn

phone no Phone Number: +13*********

Who is BIOLOGICAL MIMETICS

Biological Mimetics, Inc. (BMI) was formed to commercialize innovative pharmaceutical products that will improve the quality of life and overall state of public health by combating resist...

Read More

map
  • 124 Byte Dr, Frederick, Maryland, 21702, United States Headquarters: 124 Byte Dr, Frederick, Maryland, 21702, United States
  • 1996 Date Founded: 1996
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from BIOLOGICAL MIMETICS

Biological Mimetics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Biological Mimetics

Answer: Biological Mimetics's headquarters are located at 124 Byte Dr, Frederick, Maryland, 21702, United States

Answer: Biological Mimetics's phone number is +13*********

Answer: Biological Mimetics's official website is https://biologicalmimetics.com

Answer: Biological Mimetics's revenue is $5 Million to $10 Million

Answer: Biological Mimetics's SIC: 2834

Answer: Biological Mimetics's NAICS: 325412

Answer: Biological Mimetics has 11-50 employees

Answer: Biological Mimetics is in Biotechnology

Answer: Biological Mimetics contact info: Phone number: +13********* Website: https://biologicalmimetics.com

Answer: Biological Mimetics, Inc. (BMI) was formed to commercialize innovative pharmaceutical products that will improve the quality of life and overall state of public health by combating resistant and emerging diseases in human and veterinary medicine. Our mission philosophy is to remain a creative and innovative biotechnology firm dedicated to improving the quality of life and overall state of public health through the application of novel technologies for the development and commercialization of human and veterinary biologics to address a long list of hitherto intractable disease targets involving viruses, bacteria, parasites, and cancer. As a result of BMIs elucidation of Deceptive Imprinting, a mechanism of antigenic variation used by microbial pathogens and cancer cells to evade the host immune system, BMI developed Immune Refocusing Technology to circumvent such evasion mechanisms. Through the application of IRT, BMI strives to: (1) generate vaccines against pathogens for which no effective vaccine exists and (2) improve upon current strain-limited or serotype-limited protection of commercially available human and veterinary vaccines. IRT is able to alter the natural antigenicity and immunogenicity of targeted protein antigens making it a valuable tool to induce and select monoclonal antibodies. IRT can also be utilized to immune dampen therapeutic proteins and biologics to improve biological half-life and safety profiles.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access